Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with Biosero, a developer of laboratory automation solutions, to enable and facilitate robotic arm integration with BD flow cytometry instruments.

BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development.